Study Finds Improved Functioning for ‘Schizophrenia’ Without Antipsychotics
Long-term treatment with antipsychotic drugs is currently considered the standard treatment for patients diagnosed with ‘schizophrenia.’ A new study challenges this practice, however. The...
Peer-Support Groups Were Right, Guidelines Were Wrong: Dr. Mark Horowitz on Tapering Off Antidepressants
In an interview with MIA, Dr. Horowitz discusses his recent article on why tapering off antidepressants can take months or even years.
Adverse Emotional and Interpersonal Effects of Antidepressants
Adverse effects of antidepressants, including sexual difficulties and emotional numbing, apathy, suicidality and withdrawal effects may be more frequent than previously reported, according to...
Children on Antipsychotics 50% More Likely to Develop Diabetes
Antipsychotic drugs increased the risk of children developing diabetes by 50%, and with an antidepressant added, their risk doubled.
STOP or GO? Tapering Pregnant Women off of Antidepressants
A team in the Netherlands is currently investigating the effects of tapering off of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) during pregnancy....
New Research on Patient-Centered Deprescribing for Antipsychotics
Researchers review the risks and benefits of deprescribing from antipsychotic drugs and advocate for a patient-centered approach to tapering.
Gradual Tapering is Most Successful for Withdrawal from Antipsychotics
Mixed-Methods study explores the experiences of antipsychotic discontinuation among service users.
Lilly Faces First Week of “Bellwether” Cymbalta Withdrawal Lawsuit
Calling it “Poison,” plaintiff Claudia Herrera testified she would not have taken Eli Lilly's drug Cymbalta had she known the risks. Lilly hid the risks of...
Fear and Belief in “Chemical Imbalance” Prevent People from Coming Off Antidepressants
Researchers interviewed people who were given medical advice to discontinue antidepressants.
SNRIs Added to the List of Drugs with Potential Withdrawal Symptoms
New research suggests that clinicians should exercise caution prescribing SNRIs as first-line treatment for mood and anxiety disorders.
New Clinical Guidelines on Deprescribing Benzodiazepines
New guidelines recommend deprescribing benzodiazepine receptor agonists for adults.
J&J Loses Case Over Risperdal Antipsychotic Causing Male Breast Growth
A jury decided Johnson & Johnson must pay a Philadelphia man $2.5 million in damages "for failing to warn that its Risperdal antipsychotic could cause gynecomastia."
More Psychological Supports Needed to Manage Antidepressant Discontinuation
Study reviews psychological interventions for antidepressant discontinuation.
Pfizer Accused of Knowing Zoloft Antidepressant Caused Birth Defects
The first of more than 1,000 lawsuits about Zoloft and birth defects has gotten underway.
Danish Study Finds Better 10-year Outcomes in Patients Off Antipsychotics
Study finds that 74% of patients with a psychotic disorder off antipsychotics at end of 10 years are in remission.
Pfizer Sued Over Zoloft’s Failure to Beat Placebo
A lawsuit filed Wednesday in San Jose, California seeks federal approval for two class-action lawsuits representing all U.S. users of the antidepressant Zoloft, accusing...
Antidepressants Linked to Doubling of Failure of Dental Implants
People who take SSRI antidepressants are twice as likely to have their dental implants fail, according to McGill University researchers. In a press release,...
Very Slow Tapering Best For Antidepressant Withdrawal
A new article in Lancet Psychiatry finds that slower tapering of SSRIs is better for preventing antidepressant withdrawal effects.
Autism Linked to Antidepressants During Pregancy
A study of the Swedish medical birth registry, conducted by researchers from Sweden, the U.K., and the U.S.A., found a 3.3X greater risk of...
Semen Abnormalities Associated with SSRI Antidepressants
The French non-profit organization Prescrire has produced a special report about the impacts of SSRI antidepressants on male fertility.
Different Antipsychotics Have Different Effects on Brain Volume
First generation antipsychotics seem to cause general brain volume loss, while second generation antipsychotics seem to both increase and decrease the thickness of different parts of the brain.
